BEAM
Beam Therapeutics Inc
24.40$
-6.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | -400,016.7% | -398,920.8% | -127.8% | 37.0% | -39.5% | -546.7% | -247.0% | |
| – | – | 19,461.1% | 19,729.2% | 14.4% | 23.2% | 5.3% | 34.5% | 16.0% | |
| – | – | 39,044.4% | 64,083.3% | 84.0% | 138.4% | 26.1% | 190.0% | 67.4% | |
| – | – | 75,138.9% | 369,870.8% | 358.1% | 27.8% | – | – | – | |
| – | – | -59,472.2% | 22,279.2% | 214.6% | 413.0% | -30.8% | -173.5% | -93.8% | |
| – | – | 69,544.4% | 68,154.2% | 90.3% | 80.4% | 8.9% | 14.1% | 10.7% | |
| – | – | -370,327.8% | -417,179.2% | -567.4% | -757.3% | 19.0% | 291.3% | -86.9% | |
| – | – | 70,633.3% | – | – | – | – | – | – | |
| – | – | -139,927.8% | – | 1,462.6% | – | – | – | – | |
| – | – | 31,744.4% | 7,075.0% | -4.1% | -3.8% | -0.6% | -0.8% | 0.0% | |
| – | – | 229,327.8% | 1,343,008.3% | 1,458.5% | 183.2% | 73.2% | 12.2% | 342.1% | |
| – | – | -541,016.7% | 526,908.3% | 763.3% | -537.1% | 52.7% | -243.2% | 8.2% | |
| – | – | -469,561.1% | -467,075.0% | -218.1% | -43.4% | -48.4% | -560.8% | -257.7% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.